Cargando…

Role of cancer-associated fibroblasts in the progression, therapeutic resistance and targeted therapy of oesophageal squamous cell carcinoma

Oesophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignant tumours with high morbidity and mortality. Although surgery, radiotherapy and chemotherapy are common treatment options available for oesophageal cancer, the 5-year survival rate remains low after treatment. On the on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Mengying, Tong, Yusuo, Xiong, Yaozu, Yu, Changhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623436/ https://www.ncbi.nlm.nih.gov/pubmed/37927475 http://dx.doi.org/10.3389/fonc.2023.1257266

Ejemplares similares

Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs
por: Tong, Yusuo, et al.
Publicado: (2020)

Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy
por: Kozumi, Maiko, et al.
Publicado: (2018)

Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma
por: Yanagi, Teruki, et al.
Publicado: (2018)

Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis
por: Twarock, Sören, et al.
Publicado: (2011)

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma
por: Luo, Qiyu, et al.
Publicado: (2021)

CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2021)

Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma
por: Shao, Taihang, et al.
Publicado: (2022)

Pirfenidone for the prevention of radiation-induced lung injury in patients with locally advanced oesophageal squamous cell carcinoma: a protocol for a randomised controlled trial
por: Chen, Cheng, et al.
Publicado: (2022)

The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Cheng, Yali, et al.
Publicado: (2021)

Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population
por: van de Ven, Steffi E. M., et al.
Publicado: (2021)

Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model
por: Kong, Jie, et al.
Publicado: (2021)

Clinical impact of Fn-induced high expression of KIR2DL1 in CD8 T lymphocytes in oesophageal squamous cell carcinoma
por: Wang, Xiaopeng, et al.
Publicado: (2021)

Inflammatory biomarkers as predictors of immune activation to different irradiated sites and short-term efficacy in advanced squamous cell esophageal carcinoma received radioimmunotherapy
por: Li, Mengying, et al.
Publicado: (2023)

MiR‐130b promotes the progression of oesophageal squamous cell carcinoma by targeting SASH1
por: Zhu, Yuxing, et al.
Publicado: (2018)

Giant squamous cell carcinoma of penis with rapid progression
por: Zhang, Yongrui, et al.
Publicado: (2020)

Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma
por: Lei, Huimin, et al.
Publicado: (2022)

Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
por: Petrusca, Daniela N., et al.
Publicado: (2022)

Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma
por: Nakajima, M, et al.
Publicado: (2003)

Association between alcohol consumption and oesophageal microbiota in oesophageal squamous cell carcinoma
por: Rao, Wenqing, et al.
Publicado: (2021)

Identification of CHRNB4 as a Diagnostic/Prognostic Indicator and Therapeutic Target in Human Esophageal Squamous Cell Carcinoma
por: Li, Nan, et al.
Publicado: (2020)

miR-27a Downregulation Promotes Cutaneous Squamous Cell Carcinoma Progression via Targeting EGFR
por: Wang, Yinghui, et al.
Publicado: (2020)

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study
por: Rochigneux, Philippe, et al.
Publicado: (2022)

Expression of Osteopontin in oesophageal squamous cell carcinoma
por: Kita, Y, et al.
Publicado: (2006)

Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma
por: Baker, Lauren C. J., et al.
Publicado: (2018)

Cancer-associated fibroblasts in hematologic malignancies: elucidating roles and spotlighting therapeutic targets
por: Ding, Ziyang, et al.
Publicado: (2023)

Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma
por: Kamarajah, Sivesh K, et al.
Publicado: (2023)

BCL11A Promotes the Progression of Laryngeal Squamous Cell Carcinoma
por: Zhou, Jian, et al.
Publicado: (2020)

Integrative Multi−Omics Analysis Reveals Candidate Biomarkers for Oral Squamous Cell Carcinoma
por: Wan, Zhengqing, et al.
Publicado: (2022)

Stromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic Target
por: Elkhattouti, Abdelouahid, et al.
Publicado: (2015)

The recent advances of cancer associated fibroblasts in cancer progression and therapy
por: Wu, Chenxi, et al.
Publicado: (2022)

Comparative clinical studies of primary chemoradiotherapy versus S-1 and nedaplatin chemotherapy against stage IVb oesophageal squamous cell carcinoma: a multicentre open-label randomised controlled trial
por: Liu, Yun, et al.
Publicado: (2022)

Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma – Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes
por: Bogowicz, Marta, et al.
Publicado: (2021)

RAD001 targeted HUVECs reverses 12‐lipoxygenase‐induced angiogenesis in oesophageal squamous cell carcinoma
por: Chen, Xue, et al.
Publicado: (2021)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

LncRNA FENDRR in Carcinoma-Associated Fibroblasts Regulates the Angiogenesis of Oral Squamous Cell Carcinoma Through the PI3K/AKT Pathway
por: Xu, Yuming, et al.
Publicado: (2021)

Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Knops, Alexander M., et al.
Publicado: (2020)

Oral Microbiome in Patients with Oesophageal Squamous Cell Carcinoma
por: Wang, Qian, et al.
Publicado: (2019)

Oesophageal squamous cell carcinoma mimicking submucosal tumour
por: Wang, Wen, et al.
Publicado: (2021)

Risk factors for oesophageal squamous cell carcinoma in Mozambique
por: Cunha, Lina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iesqucrsk7g2bi7ilrn9ekfegf